RIGEL PHARMACEUTICALS INC - RIGL
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 03, 2026 | EVP & Chief Financial Officer | M | D | 1,286.0 | 0.0 | 0.0 | 15,867.0 | View | |
| Sep 03, 2026 | EVP & Chief Financial Officer | M | D | 2,000.0 | 0.0 | 0.0 | 7,999.0 | View | |
| Sep 03, 2026 | EVP & Chief Financial Officer | M | D | 620.0 | 0.0 | 0.0 | 9,012.0 | View | |
| Sep 03, 2026 | EVP & Chief Financial Officer | M | D | 694.0 | 0.0 | 0.0 | 12,824.0 | View | |
| Sep 03, 2026 | EVP & Chief Financial Officer | M | A | 1,286.0 | 24.2 | 31,121.2 | 82,962.0 | View | |
| Sep 03, 2026 | EVP & Chief Financial Officer | M | A | 2,000.0 | 24.2 | 48,400.0 | 81,676.0 | View | |
| Sep 03, 2026 | EVP & Chief Financial Officer | M | A | 620.0 | 18.7 | 11,594.0 | 79,676.0 | View | |
| Sep 03, 2026 | EVP & Chief Financial Officer | M | A | 694.0 | 12.7 | 8,813.8 | 79,056.0 | View | |
| Sep 03, 2026 | EVP & Chief Financial Officer | F | D | 928.0 | 47.5 | 44,080.0 | 78,362.0 | View | |
| Sep 03, 2026 | EVP, Chief Commercial Officer | F | D | 874.0 | 47.5 | 41,515.0 | 61,622.0 | View | |
| Sep 03, 2026 | CEO, President | F | D | 2,424.0 | 47.5 | 115,140.0 | 273,362.0 | View | |
| Sep 03, 2026 | EVP, GC, CCO & Corp Sec | F | D | 877.0 | 47.5 | 41,657.5 | 50,559.0 | View | |
| Jul 10, 2026 | EVP, Chief Medical Officer | A | A | 24,400.0 | 0.0 | 0.0 | 35,025.0 | View | |
| Jun 24, 2026 | — | S | D | 2,500.0 | 35.0 | 87,500.0 | 10,125.0 | View | |
| Jun 22, 2026 | EVP, GC, CCO & Corp Sec | A | A | 7,394.0 | 0.0 | 0.0 | 7,394.0 | View | |
| Jun 22, 2026 | EVP, Chief Medical Officer | A | A | 7,394.0 | 0.0 | 0.0 | 7,394.0 | View | |
| Jun 22, 2026 | EVP, Chief Medical Officer | A | A | 9,375.0 | 0.0 | 0.0 | 9,375.0 | View | |
| Jun 22, 2026 | CEO, President | A | A | 31,700.0 | 0.0 | 0.0 | 31,700.0 | View | |
| Jun 22, 2026 | EVP, Chief Commercial Officer | A | A | 7,394.0 | 0.0 | 0.0 | 7,394.0 | View | |
| Jun 22, 2026 | EVP & Chief Financial Officer | A | A | 7,394.0 | 0.0 | 0.0 | 7,394.0 | View | |
| Jun 03, 2026 | EVP & Chief Financial Officer | M | D | 2,181.0 | 0.0 | 0.0 | 13,518.0 | View | |
| Jun 03, 2026 | EVP & Chief Financial Officer | M | D | 1,200.0 | 0.0 | 0.0 | 9,632.0 | View | |
| Jun 03, 2026 | EVP & Chief Financial Officer | F | D | 928.0 | 29.86 | 27,710.08 | 78,790.0 | View | |
| Jun 03, 2026 | EVP & Chief Financial Officer | M | A | 2,181.0 | 12.7 | 27,698.7 | 79,718.0 | View | |
| Jun 03, 2026 | EVP & Chief Financial Officer | M | A | 1,200.0 | 18.7 | 22,440.0 | 77,537.0 | View | |
| Jun 03, 2026 | EVP, Chief Commercial Officer | F | D | 874.0 | 29.86 | 26,097.64 | 61,996.0 | View | |
| Jun 03, 2026 | EVP, Chief Medical Officer | F | D | 850.0 | 29.86 | 25,381.0 | 34,003.0 | View | |
| Jun 03, 2026 | CEO, President | F | D | 2,424.0 | 29.86 | 72,380.64 | 279,593.0 | View | |
| Jun 03, 2026 | EVP, GC, CCO & Corp Sec | F | D | 877.0 | 29.86 | 26,187.22 | 50,936.0 | View | |
| May 28, 2026 | — | S | D | 2,500.0 | 29.17 | 72,925.0 | 12,625.0 | View | |
| May 19, 2026 | — | A | A | 5,750.0 | 0.0 | 0.0 | 18,250.0 | View | |
| May 19, 2026 | — | A | A | 5,750.0 | 0.0 | 0.0 | 18,472.0 | View | |
| May 19, 2026 | — | A | A | 5,750.0 | 0.0 | 0.0 | 5,937.0 | View | |
| May 19, 2026 | — | A | A | 5,750.0 | 0.0 | 0.0 | 18,250.0 | View | |
| May 19, 2026 | — | A | A | 5,750.0 | 0.0 | 0.0 | 16,375.0 | View | |
| May 19, 2026 | — | A | A | 5,750.0 | 0.0 | 0.0 | 7,000.0 | View | |
| May 19, 2026 | — | A | A | 5,750.0 | 0.0 | 0.0 | 15,125.0 | View |